- Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis
- Legionnaires’ Effect on Smell
- Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.
- Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011.
- Special Investigation Of Azithromycin IV For Legionnaires’ Disease (Regulatory Post Marketing Commitment Plan)
Clinical Trials
- A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors
- A Study of PTC596 in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
- A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
- A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
- Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
- Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
- Circulating ” Cancer Cells / Macrophage ” HYbrid Cells in Patients With Sarcoma, Part 2
- Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchimal Malignant Tumors
- CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
- Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma
- Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
- Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine
- Exploring Clinical Trial Experiences of People With Leiomyosarcoma
- Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
- Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
- Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
- LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
- Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
- S9624 Ifosfamide in Treating Patients With Meningeal Tumors
- Targeting ATR in Soft-tissue Sarcomas
- Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
- Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma
- A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies
- A Community Trial for Visceral Leishmaniasis (VL)
- A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
- A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh
- A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
- A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
- Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
- Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
- Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
- Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
- Amphotericin B Treatment in Visceral Leishmaniasis
- An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
- An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis
- Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
- Asymptomatic Leishmania Infection in HIV Patients
- Clinical Investigation of Infections Due to Leishmanial Parasites
- Clinical Prognostic Score to Predict Relapse in VL
- Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
- Combination Chemotherapy for the Treatment of Indian Kala-Azar
- Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
- Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
- Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application
- Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
- Diagnosis and Treatment of Leishmanial Infections
- Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia
- Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.
- Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
- Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India
- Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
- Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
- Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
- Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
- Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya
- Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
- Expression of Mif Alleles in Individuals With Leishmaniasis
- Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
- Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.
- Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West Bank
- High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
- Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
- Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
- Immunogenetics of Visceral Leishmaniasis
- Improved Case Detection and Vector Control for Visceral Leishmaniasis
- Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
- Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
- LAMP Assay for the Diagnosis of Visceral Leishmaniasis
- LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine
- Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis
- Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection
- Mediterranean Visceral Leishmaniasis With Leishmania Infantum
- Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
- Miltefosine and GM-CSF in Cutaneous Leishmaniasis
- Miltefosine for Brazilian Visceral Leishmaniasis
- Miltefosine for Mucosal Leishmaniasis
- Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
- Miltefosine to Treat Mucocutaneous Leishmaniasis
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
- Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
- Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
- Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
- Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
- Pharmacokinetics of Miltefosine in Children and Adults
- Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
- Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers
- Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers
- Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
- Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
- Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
- Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre
- Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
- Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis
- Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
- Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
- Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
- Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
- Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
- Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite
- Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen
- Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants
- Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects
- SCH708980 With and Without AmBisome for Visceral Leishmaniasis
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
- Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
- Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
- Single Oral Dose Escalation Study of DNDI-0690 in Healthy Male Subjects
- Sodium Stibogluconate Treatment of Leishmaniasis
- Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition
- Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite
- Surveillance for Leishmaniasis Skin Lesions in Mali
- Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes
- The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
- Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
- Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
- Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
- Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
- Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
- Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
- Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan
- Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
- Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia
- WR 279,396 for the Treatment of Cutaneous Leishmaniasis
- WR 279,396 Open Label Treatment Protocol in Tunisia
- Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
- Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
- CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum
- Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
- Ciclosporin in the Management of New Erythema Nodosum Leprosum
- Ciclosporin in the Management of New Type 1 Reactions in Leprosy
- Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
- Effect of Weight and/or Obesity on Dapsone Drug Concentrations
- Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
- Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial
- Improved Understanding of Ongoing Transmission of Leprosy in the Hyperendemic Comoros (ComLep)
- Leprosy Skin Test Antigens Phase 1
- Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses
- Molecular Epidemiology of Leprosy – Philippines
- Montelukast in ENL Reaction
- Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers
- Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
- Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
- Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients
- The Effect of “Jinchuang Ointment” (JCO) on the Treatment of Wounds in Patients With Hansen’s Disease.
- The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
- The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients
- Treatment of Neuropathic Pain in Leprosy
- Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
- Uniform Multidrug Therapy Regimen for Leprosy Patients
- Photodynamic Therapy for Oral Precursor Lesions
- Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis – Phase 2 Clinical Trial
- Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR
- Cardiac Magnetic Resonance in Children With Muscular Dystrophy
- Cardiac Outcome Measures in Children With Muscular Dystrophy
- Cell Therapy in Limb Girdle Muscular Dystrophy
- Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet)
- Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
- Molecular Analysis of Patients With Neuromuscular Disease
- MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
- Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
- Stem Cell Therapy in Limb Girdle Muscular Dystrophy
- Study Evaluating MYO-029 in Adult Muscular Dystrophy
- Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
- Weekly Steroids in Muscular Dystrophy
- 3 Year Follow up on ANO5 Patients
- A Phase 1/2 Dose-escalation Study to Evaluate the Safety of LION-101 in Adult Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
- A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
- Biomarker Development in LGMD 2i
- Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
- Limb-Girdle Muscular Dystrophy Type 2I in Norway
- MRI and Muscle Involvement in Patients With Mutations in GMPPB
- MRI on Persons With Mutations in POMT2 Gene (LGMD2N)
- Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
- Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E
- Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
- Trial Readiness and Endpoint Assessment in LGMD R1
- A Study of the Natural History of Patients With LGMD2E, LGMD2D, and LGMD2C, ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
- Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)
- Gene Delivery Clinical Trial of SRP-9003 for Patients With LGMD2E (Beta-sarcoglycan Deficiency)
- Limb Girdle Muscular Dystrophy Type 2E Recruitment Study
- A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
- A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
- A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy
- Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity
- An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
- Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
- Body Composition and Adipose Tissue in HIV
- Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals
- Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil
- Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
- Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference
- Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
- Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
- Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy
- Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
- Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
- Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
- CONFORM: Rotational Fractional Resection for Submental Contouring
- Corticosteroid-induced Lipodystrophy and Adipokines
- Detraining in People Living With HIV/AIDS
- Different Surgical Modalities for Thigh Lipodystrophy Including Liposuction,Thigh Lift and Liposuction Assisted Thigh Lift
- Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.
- Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults
- Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
- Effects of Growth Hormone Releasing Hormone in HIV
- Effects of IGF-I in HIV Metabolic Disease
- Effects of Short-term Growth Hormone in HIV-infected Patients
- Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
- Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
- Egrifta Replacement and Sleep Disordered Breathing
- Energy Expenditure of People Living With HIV/AIDS
- Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects
- Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects
- Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects
- Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects
- Exercise and Pioglitazone for HIV-Metabolic Syndromes
- Exercise for Patients With HIV Infections
- Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan’s Lipodystrophy
- Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
- Growth Hormone Dynamics and Cardiac Steatosis in HIV
- Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
- Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults
- Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich Formula
- Lactate Metabolism Study in HIV Infected Persons
- Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
- Leptin to Treat Lipodystrophy
- Leptin to Treat Lipodystrophy
- Lipodystrophy Connect Patient Registry
- Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
- Low Energy Diet and Familial Partial Lipodystrophy
- Metabolic Abnormalities in HIV-infected Persons
- Metabolism and Body Shape of Healthy Children and Children With Chronic Infections
- Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities
- Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
- Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
- Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults
- Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
- Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
- Pravastatin for Hyperlipidaemia in HIV.
- Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances
- Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS
- Raltegravir Therapy for Women With HIV and Fat Accumulation
- Role of the Autonomic Nervous System in HIV-Lipodystrophy
- Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids
- Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections
- Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
- Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid
- Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
- SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
- Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat
- Short-term Effects of Leptin in People With Lipodystrophy
- Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy
- Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
- Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy
- Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue
- Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.
- TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
- TH9507 in Patients With HIV-Associated Lipodystrophy
- The Cleveland Cardiometabolic Cohort
- The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
- The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
- The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients
- The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS
- The PREFORM Study: A Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
- The Visceral Adiposity Measurement and Observation Study
- Therapeutic Approaches to HAART-Induced Lipodystrophy
- Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
- Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome
- White Light Scanning to Aid Body Contouring: A Pilot Project
- Yoga for the Management of HIV-Metabolic Syndromes
- A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
- A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
- APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
- ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
- Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
- Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
- Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma
- Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
- Patient Reported Outcome Measures (PROMs) With Trabectedin
- PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
- Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
- Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma